Shay Capital LLC 13D and 13G filings for PharmaCyte Biotech, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:30 pm Sale |
2022-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB |
Shay Capital LLC | 0 0.000% |
-1,037,882 (Position Closed) |
Filing |
| 2022-10-20 10:38 am Purchase |
2022-10-10 | 13G | PharmaCyte Biotech, Inc. PMCB |
Shay Capital LLC | 1,037,882 5.000% |
1,037,882 (New Position) |
Filing |